In a recent study posted to the medRxiv* preprint server, researchers developed a personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes, i.e., sodium-glucose cotransporter 2 (SGLT2)-inhibitors (SGLT2i, reference class) and glucagon-like peptide-1 (GLP1)-receptor agonist (GLP1-RA) medications
ARDs, which include rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and axial spondyloarthritis, are characterised with chronic systemic inflammation that accelerates atherogenesis and substantially increases premature cardiovascular death
You are gonna lose muscle if you don't do something about it, but you can do something about it, that is the beautiful thing
The role of PBMs and obesity care solutions: a collaborative effort Plan sponsors need to choose obesity solutions partners strategically
Dose escalation schedules are brand-specificfor example, Wegovy (semaglutide for weight management) follows a weekly titration schedule, while Saxenda (liraglutide for weight management) has a daily titration protocol
When you give attention to both medicine and daily habit changes, people get better results